Loading company…
Promedius develops AI tools for medical image analysis and screening.
Founded in 2019 and based in Seoul, South Korea, Promedius uses deep learning to support medical image reconstruction and diagnosis. Its PROS® CXR: OSTEO system analyzes chest X-rays to screen for osteoporosis and generate a risk score. In June 2026, it raised KRW 21.5 billion in Series B funding from the listed investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in